Scientists have restored visual responses in blind mice by transplanting artificial replacements for light-detecting cells into their eyes. [ + ]

The moratorium on genetically modified crops in South Australia does not deliver price premiums to any farmer in the state, according to market analysis company Mecardo. [ + ]

Zelda Therapeutics, an Australian-listed biotech focused on medical cannabis, has expanded its pancreatic cancer research collaboration agreement with Curtin University. [ + ]

UQ researchers are using what is said to be the largest set of multilevel genomic data ever compiled to pinpoint the genes within our DNA that are linked to specific diseases. [ + ]

EnGeneIC's bacterially derived nanocells are enhancing the delivery of chemotherapy to tumours, while limiting toxicity to normal tissues, in aggressive paediatric neuroblastoma. [ + ]

Adelaide researchers have developed and patented a novel approach to fight superbugs by targeting the bugs' favourite food, iron. [ + ]

Belgian researchers have devised a novel approach to developing antibacterial drugs, in a breakthrough that is set to combat the rise of antibacterial resistance. [ + ]

Zika virus could be used for treatment of glioblastoma, according to Brazilian researchers. [ + ]

Researchers have identified heritable but non-genetic markers for breast cancer susceptibility, in a breakthrough that will enable doctors to better predict cancer risk. [ + ]

Australian and Dutch researchers have moved a step closer towards making human kidneys from stem cells. [ + ]

Clarivate Analytics has partnered with IP Australia by providing its enhanced patent data to augment its Source IP database. [ + ]

New worker mental health management guidelines are currently being canvassed, with community input accepted until mid-March, according to WorkCover Queensland. [ + ]

Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA). [ + ]

Okogen, a developer of ophthalmic anti-infective drugs, has received $13m from the Medical Research Commercialisation Fund to advance its viral conjunctivitis treatment. [ + ]

Projects outcomes include the development of 3D-printed materials for the vision impaired, improved grain crop production through better weed control and innovations in advanced composite paints. [ + ]